MedPath

Modification of Complications in Infertile Men with Varicocele by Curcumin Nanomicels

Not Applicable
Recruiting
Conditions
Varicocele.
Scrotal varices
I86.1
Registration Number
IRCT20170923036334N3
Lead Sponsor
Iranian academic center for education culture and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
100
Inclusion Criteria

Infertile Men with Varicocele

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Levels of Sex Hormones. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Eliza Kit.;Sperm Parameters. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Standard Clinical Analysis of Semen for Evaluation of Sperm Parameters with The Usual Laboratory Method and Light Microscope According to the Organization CriteriaWHO-2010 World Health Takes Place.;Oxidative Stress Rate. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: ROS Positive Sperms were Evaluated Using H2DCFDA (DCFH - DA: 2 ', 7'-dichlorodihydrofluoresceindiacetat) (Sigma Co., USA) and Analyzed by Flow Cytometry.
Secondary Outcome Measures
NameTimeMethod
Viability. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Viability is Assessed by Eosin-Nigrosin Staining and Examined Using a Light Microscope.;DNA Damage Assessment. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Tunnel Kit.;Measurement of Sperm Mitochondrial Activity. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Rhodamine Staining is Used to Assess the Mitochondrial Activity of Sperm.
© Copyright 2025. All Rights Reserved by MedPath